Conclusions
The findings presented in this report show that: (1) 5-lipoxygenase inhibitors and some leukotriene antagonists protect the gastric mucosa against lesions induced by oral or parenteral administration of most NSAIDs, with the possibility of some variation in effects with aspirin.
(2) These observations suggest that overproduction of leukotrienes and other products of 5-lipoxygenase activity may play a role in the development of acute gastric mucosal damage induced by NSAIDs.
Similar content being viewed by others
References
B. J. R. Whittle,Arachidonic acid metabolites and the gastrointestinal toxicity of antiinflammatory agents. Prostaglandins21, (Suppl.), 113–118 (1981).
K. D. Rainsford,Mechanisms of gastric contrasted with intestinal damage by nonsteroidal antiinflammatory drugs. In:Side Effects of Antiinflammatory Drugs. Vol. II (Eds.: K. D. Rainsford and G. P. Velo) pp. 3–26. MIP Press, Lancaster 1987.
J. R. Walker and J. Harvey,Actions of antiinflammatory drugs on leukotriene and prostaglandin metabolism: relationships to asthma and other hypersensitivity reactions. Inside effects of antiinflammatory/analgesic drugs. (Eds. K. D. Rainsford and G. P. Velo) pp. 227–238 Raven Press, New York 1984.
R. G. Pendleton and J. R. Stavorski,Evidence for differing leukotriene receptors in gastric musosa. Europ. J. Pharmacol.125, 297–299 (1986).
P. Salvati and B. J. R. Whittle,Investigation of the vascular actions of arachodonate lipoxygenase and cyclooxygenase products of the perfused stomach of rat and rabbit. Prostaglandin22, 141–156 (1981).
K. D. Rainsford,An economical and highly sensitive assay for the gastrotoxicity of antiinflammatory drugs and anti-ulcer agents, in cholinomimetically-sensitized mice. Dig. Dis. Sci.30, A32 (1985).
D. F. Magee, S. Naruse and A. Pap,Comparison of the actions of cholinomimetics and pentagastrin on gastric secretion in dogs. Br. J. Pharmacol.84, 347–355 (1985).
S. M. Coutts, A. Khandwala, R. Van Inwegen, U. Chakraborty, J. Musser, J. Bruens, N. Jariwala, V. Dally-Meade, R. Ingram, T. Puss, H. Jones, E. Neiss and I. Weinryb,Arylmethyl phenyl ethers. A new class of specific inhibitors of 5-lipoxygenase. InProstaglandins, leukotrienes, and lipoxins. (Ed. J. M. Bailey) pp. 627–637 Plenum Press, New York 1985.
Y. Guindon, Y. Girard, A. Maycock, A. W. Ford-Hutchinson, J. G. Atkinson, P. C. Belanger, A. Dallob, D. DeSousa, H. Dougherty, R. Egan, M. M. Goldenberg, E. Ham, R. Fortin, P. Hamel, R. Hamel, C. K. Lau, Y. Leblanc, C. S. McFarlane, H. Piechuta, M. Thérien, C. Yoakim and J. Rokach, L-651,392 a novel, potent and selective 5-lipoxygenase inhibitor. InAdvances in prostaglandins, thromboxane and leukotriene research. (Eds. B. Samuelsson et al.) pp. 554–557. Raven Press, New York 1987.
K. H. Leung,Selective inhibition of leukotriene C 4 synthesis in human neutrophils by ethacrynic acid. Biochem. Biophys. Res. Commun.137, 195–200 (1986).
J. Augstein, J. B. Farmer, T. B. Lee, P. Sheard and M. L. Tattersall,Selective inhibitor of slow reacting substance of anaphylaxis. Nature New Biol.245, 215–217 (1973).
T. R. Jones, R. Young, E. Champion, L. Charette, D. Denis, A. W. Ford-Hutchinson, R. Frenette, J.-Y. Gauthier, Y. Guindon, M. Kakushima, P. Masson, A. Maycock, C. McFarlane, H. Piechuta, J. Rokach and R. Zamboni,L-649,923, sodium (βS *,γR *)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl-thio)-γ-hydroxy-β-methylbenzenebutanoate, a selective, orally active leukotriene acceptor antagonist. Can. J. Physiol. Pharmacol.64, 1068–1075 (1986).
J. H. Musser, D. M. Kubrak, J. Chang and A. J. Lewis,Synthesis of ((Naphthalenylmethoxy)- and ((quinolinylmethoxy)phenyl)amino)oxoalkanoic acid esters, A novel series of leukotriene D 4 antagonists and 5-lipoxygenase inhibitors. J. Med. Chem.29, 1429–1435 (1986).
J. H. Fleisch, L. E. Rinkema, K. D. Haisch, D. Swanson-Bean, T. Goodson, P. P. K. Ho and W. S. Marshall,LY-171883, 1-(2-hydroxy-3-propyl-4-(4-(1H-tetrazol-5-yl) butoxyphenyl) ethanone, an orally active leukotriene D 4 antagonist. J. Pharmacol. Exp. Ther.233, 148–157 (1985).
G. Feuerstein,Autonomic pharmacology of leukotrienes. J. Auton. Pharmacol.5, 149–168 (1985).
J. Chang, personal communication.
K. D. Rainsford,Gastric ulcerogenicity of non-steroidal anti-inflammatory drugs in mice with mucosa sensitized by cholinomimetic treatment. J. Pharm. Pharmacol., in press (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rainsford, K.D. The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice. Agents and Actions 21, 316–319 (1987). https://doi.org/10.1007/BF01966502
Issue Date:
DOI: https://doi.org/10.1007/BF01966502